Integrated Biopharma INBP
OTC INBP
$0.18 +0.02 (+12.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Integrated Biopharma (INBP) Current Debt (2022)

Updated

Integrated Biopharma's Current Debt came in at -$417,000 for fiscal Q3 2022 (quarter ended Mar 31, 2022).

Analysis

Integrated Biopharma (INBP) Current Debt (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Procter & Gamble 336.76 Bn 292.75 Bn 10.28 Bn 1.65 Bn
2 Colgate Palmolive 67.18 Bn 62.24 Bn 3.30 Bn -85.00 Mn
3 Estee Lauder Companies 33.32 Bn 21.40 Bn 2.74 Bn -
4 Kenvue 33.09 Bn 28.70 Bn 2.30 Bn 560.00 Mn
5 Kimberly Clark 31.38 Bn 28.71 Bn 1.60 Bn -565.00 Mn
6 Church & Dwight 22.37 Bn 20.90 Bn 693.90 Mn -
7 Clorox 9.72 Bn 8.16 Bn 804.00 Mn -503.00 Mn
8 e.l.f. Beauty 6.17 Bn 5.15 Bn 398.84 Mn -
9 Reynolds Consumer Products 4.71 Bn 4.37 Bn 245.00 Mn -
10 Integrated Biopharma 5.59 Mn -14.75 Mn 28,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -417,000.00
API Access

Integrated Biopharma Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=INBP&period=max&api_key=YOUR_API_KEY